Delivery Order SPE2DB22D1017-SPE2DB25FG8PN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 20,000 unit capsules of ZENPEP DR 100s, with a ceiling value of $4,456.61. This delivery order, issued June 30, 2025 with an ultimate completion date of July 1, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,186.93 to AmerisourceBergen Drug Corp for 100 units of ZENPEP DR 40,000 capsules. This competitive award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025, and is structured as a firm fixed-price delivery order. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The Defense Logistics Agency awarded a delivery order valued at $31,256.47 to AmerisourceBergen Drug Corp for 100,000 units of Zenpep DR 40,000 unit capsules, with completion targeted for September 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and extends through...
- The Defense Logistics Agency's Medical Supply Chain awarded a $21,282.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100,000 units of Zenpep DR 60,000 unit capsules. This delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a pediatric pancreatic enzyme replacement therapy essential for patients with cystic fibrosis and pancreatic insufficiency. The award was competitively awarded with no set-aside designation and will be...
- This is a $1,275.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,296,656 units of ZENPEP DR 10,000 UNIT CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,199.06 contract is for the supply of 4,567,790,837 units of the drug ZENPEP (40,000 units per capsule, 100 capsules per bottle). The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.71 firm fixed-price delivery order covers the procurement of 4,564,544,240 units of the drug ZENPEP DR 20,000 in 100-count capsule containers. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at ten thousand five hundred ninety-nine dollars and sixteen cents ($10,599.16) to Amerisourcebergen Drug Corporation for Zenpep DR 40,000 unit capsules. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 11 through September 12, 2023. The delivery order is placed against an existing indefinite-delivery/indefinite-quantity contract vehicle to...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8PNDelivery Order
The Defense Logistics Agency awarded a $4,610.82 delivery order to AmerisourceBergen Drug Corp for ZENPEP DR 60,000 unit capsules (100-count bottles) on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The order will be fulfilled from the company's Conshohocken location. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle. The prime contract enables AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. ZENPEP (pancrelipase) is an FDA-approved enzyme replacement therapy used in digestive support, and this procurement reflects the DLA's ongoing need for specialized pharmaceutical commodities across multiple therapeutic domains to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/30/25 |